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Dietary supplementation with increased levels of vitamin E can enhance the 
immune system of C3HeB/FeJ mice to enable many of them to survive an otherwise lethal 
dose of Trypanosoma cruzi, the causative agent of Chagas' disease. To study the role of 
diet on the course of experimental Chagas' disease, C3HeB/FeJ mice were fed pelleted, 
synthetic food containing no vitamin E and selenium, 800 IU/kg vitamin E, 2 ppm 
selenium, or food containing 800 IU/kg vitamin E plus 2 ppm selenium. Mice on synthetic 
food were compared to control mice fed a commonly used Purina rodent chow # 5001. 
After diet supplementation for a minimum of 14 days, mice were infected with 103 blood-
form trypomastigotes of T. cruzi. The mean peak parasitemia for all mice fed synthetic 
food was 2.56 x 10° parasites per ml of blood compared to 1.12 x 107 parasites per ml of 
blood for the infected control group fed Purina rodent chow # 5001. This difference in 
parasitemia levels represents a fourfold lower mean peak parasitemia for mice fed 
synthetic food as compared to the infected control mice. Parasitemias were not only 
lower for all the mice fed synthetic food but also the typical sharp rise in parasitemia 
during the acute phase was not observed. After the peak in parasitemia, on day 44, the 
surviving mice had a gradual decrease in parasite numbers until there were no blood-form 
trypomastigotes seen in the peripheral circulation. Statistical analysis showed that there 
was a close correlation between the replicate cages of mice fed diets deficient in vitamin E 
and selenium and the mice fed diets containing 2 ppm selenium. There also was a close 
correlation between the mice fed diets containing 800 IU/kg vitamin E plus 2 ppm 
selenium and the mice fed diets containing 800 IU/kg vitamin E only. By day 70, the 
percent survival for mice receiving diets deficient in vitamin E and selenium was 37.5% 
(n=8) while the percent survival for mice receiving diets containing 2 ppm selenium was 
44.5% (n=9). In contrast, mice receiving diets containing 800 IU/kg vitamin E plus 2 ppm 
selenium had a percent survival of 77.8% (n=9) while the mice receiving diets containing 
800 IU/kg vitamin E had a percent survival of 80.0% (n=10). The infected control mice 
that were fed Purina rodent chow # 5001 exhibited 0% survival by day 46. Parasite 
specific antibody levels were measured by ELISA to determine any existing pattern that 
could be correlated to parasitemia and mortality. In all treatment cages of mice, antibody 
levels increased by day 35 post-infection (acute phase) and remained elevated through day 
53 post-infection (chronic phase). Mice receiving synthetic diets containing 800 IU/kg 
vitamin E not only maintained the lowest mean peak parasitemias but also maintained the 
highest percent survival. These results suggested that increased dietary intake of vitamin 
E can have a pronounced effect on the course of experimental Chagas' disease. 
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INTRODUCTION 
Chagas' Disease 
Chagas' disease or American Trypanosomiasis was first described in 1909 by 
Carlos Chagas and today the disease infects approximately 10-24 million people in South 
and Central America (Wendel and Gonzaga, 1993; Molyneux, 1993). The etiological 
agent of Chagas' disease, Trypanosoma cruzi, is a eukaroytic, protozoan parasite that also 
can infect between 100-150 species of wild and domesticated mammals. Besides humans, 
natural reservoirs for T. cruzi are skunks, opossums, marmots, armadillos, sloths, bats, 
foxes, jaguars, ferrets, raccoons, rabbits, mice, hamsters, squirrels, monkeys and 
marmosets. It is not certain how many of these mammals act as reservoirs of human 
infection but the armadillo, which has a long lifespan, is important because it can harbor 
the T. cruzi infection for years (Molyneux, 1993). 
Life Cycle of T. cruzi 
The vectors are hematophagus bugs of the family Reduviidae, and these Reduvid 
bugs commonly infest huts and human dwellings in Central and South America. The three 
genera of the family Reduviidae that are important in the spread of the human disease are 
Panstrongylus, Triatoma and Rhodnius. The Reduvid bugs are commonly referred to as 
"kissing bugs" because they normally bite humans on the uncovered face while they are 
asleep. After the "kissing bug" punctures the skin and takes a blood meal, the infected 
bug defecates on the skin. The feces contain infective trypomastigotes which enter the 
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host by localized scratching or through mucous membranes near the feeding site. Once 
the trypomastigotes invade the host, they enter various cells for which they have a 
particular affinity for cells such as macrophages, muscles cells and nerve cells. The 
trypomastigotes transform into the amastigote stage within the host cell; it is this form that 
enables the parasite to multiply. The ultimate result of the multiplication of amastigotes is 
lysis of the host cell and release of the blood-form trypomastigotes (BFT) into the 
peripheral blood stream. The circulating trypomastigotes are now infective for any of the 
31 species of the Reduvid bugs that can transmit Chagas' disease when a blood meal is 
obtained from the vertebrate host. The blood-form trypomastigotes can also invade other 
host cells and repeat the vertebrate host cycle (Bogitsh and Cheng, 1990; Wendel and 
Gonzaga, 1993). Figure 1 shows the life cycle of T. cruzi in humans and in the insect 
Panstrongylus megistus ("kissing bug"). 
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Figure 1. Life cycle of Trypanosoma cruzi in 
humans and in the insect Panstrongylus 
megistus (Bogitsh and Cheng, 1990). 
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Pathology of Chagas' Disease 
The amastigote evades destruction within macrophages by escaping from the 
phagosome before lysosomal fusion occurs. Once the amastigote is safely in the 
cytoplasm of the infected macrophage, the parasite will multiply until the cell ruptures and 
releases the trypomastigote stages of the parasite. The nervous system, reproductive 
systems, intestines and bone marrow are sometimes invaded by the parasite (Bogitsh and 
Cheng, 1990; Molyneux, 1993). 
In early stages of Chagas' disease, the parasites are numerous in the infected 
tissues and the peripheral blood. As the infection commonly moves toward the chronic 
phase, the number of parasites in the circulation decreases drastically, until the parasites 
are no longer found in the peripheral circulation. In acute cases, about one to three weeks 
after infection, fever, headache and enlargement of the liver and spleen are examples of 
some of the physiological changes caused by the parasite (Bogitsh and Cheng, 1990). T. 
cruzi causes long term autoimmune reactions which can lead to the death of infected and 
uninfected host cells. These autoimmune reactions can lead to cardiac failure if the heart 
becomes infected with the parasite. Chagas' disease is further complicated by the fact that 
the parasite expresses antigens on it's surface that can cross-react with those of the host 
muscle and nerve cells, also leading to autoimmune reactions (Molyneux, 1993). 
Besides evading the lysosomal action of the infected cells, some trypomastigotes 
can cleave immunoglobulin molecules and inhibit complement lysis. T. cruzi can also 
suppress Interleukin 2 (IL-2) synthesis and down regulate IL-2 receptor expression which 
contributes to the immunodepressed state that classically occurs with the infection. 
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Amastigotes within macrophages can be killed if the host cells are activated by Interferon-
gamma, but this mechanism does not occur in muscle or nerve cells, much to the 
advantage of the parasite (Molyneux, 1993). Cytotoxic T-lymphocytes and natural killer 
cells are primarily responsible for lysis of the parasite; however, all of the phagocytic 
immune cells can play a role in the engulfment and killing of the various stages of the T. 
cruzi parasite (Kuhn, 1989). 
There are no known cures for Chagas' disease, although a few therapeutic 
approaches are successful at relieving symptoms if used early in the onset of the acute 
phase of infection. Once an infection has moved from the acute phase to the chronic 
phase, there are no guaranteed treatments to successfully relieve the enlargement of 
infected organs, or megasyndromes, that can occur (Wendel and Gonzaga, 1993). 
Transmission of Chagas' Disease 
Wendel and Gonzaga (1993) report that there may be 50,000 immigrants infected 
with T. cruzi living in the United States alone. They also noted that in Europe, there 
might be greater than 300,000 Brazilian immigrants and in Japan there are over 150,000 
Brazilian immigrants. T. cruzi can be transmitted through blood transfusion or blood 
components with the exclusion of blood derivatives subjected to sterilization procedures. 
Other methods of transmission of Chagas' disease include congenital transmission or 
breast feeding (Skolnick, 1991). Blood transfusion is the second most important mode of 
transmission in endemic areas. Transfusion transmitted Chagas' disease may be changing 
its geographical limits as emigration, especially to North America, increases. At the 
present time, American Red Cross (ARC) blood banks are not required to screen blood or 
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blood components for the presence or past-presence of Chagas' disease. There are no 
serological procedures to screen for Chagas' disease that have approval of the Federal 
Drug Administration (FDA), and this fact undermines any efforts at eliminating 
transmission of Chagas' disease by blood transfusion or transfusion of blood components. 
Organ donations from T. cruzi infected individuals can also be involved in transmission of 
Chagas' disease. The difference in the types of transmission noted above versus insect 
transmission is that the chagoma of inoculation, a characteristic swelling of the skin, face, 
or eyelids, is not seen. Fever is the most common and often the only symptom of Chagas' 
disease transmitted by organ donations, blood or blood component transfusion (Wendel 
and Gonzaga, 1993). 
T. cruzi is viable in refrigerated whole blood for 18 days or more and has been 
shown to survive freezing temperatures for at least 24 hours. Hemophiliacs have been 
infected when treated with cryoprecipitate (Factor 8) that has been in the blood bank 
freezer for 24 hours or less (Wendel and Gonzaga, 1993). A small number of parasites 
must survive the initial humoral and cell-mediated response in order to establish an active 
infection in their mammalian hosts. 
Vitamin E and Selenium 
Vitamin E and selenium are essential for the integrity and optimal functioning of all 
mammalian cells since both are involved in the stability of biological membranes (Sheffy 
and Schultz, 1979). Selenium, long known for its toxicity, was shown in 1969 to be an 
essential trace element in the nutrition of chicks and rats (Thompson and Scott, 1969; 
McCoy and Weswig, 1969). Selenium is now an approved additive to animal feeds 
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(Jenkins and Hidiroglou, 1972). Even before an absolute requirement for selenium was 
established, small amounts of selenium were found to protect rats against liver necrosis 
brought on by vitamin E deficiency (Spallholz et al., 1973). Several diseases of domestic 
and research animals, such as exudative diathesis in chicks, necrotic liver disease in swine, 
white muscle disease in ruminants and myopathy of the heart and gizzard in poultry, 
responded favorably to selenium as well as vitamin E supplementation (Nockels, 1979; 
Vergroesen and Crawford, 1989). 
The metabolic role of selenium is linked with that of vitamin E in that the two 
elements act in a synergistic manner to protect body cells from oxidation which can lead to 
cell death. Some diseases associated with low concentrations of selenium (less than 0.1 
ppm) are similar to disease conditions caused by vitamin E deficiency and are usually 
manifested under conditions of low intake of vitamin E. In some instances, these 
syndromes have been observed to respond fully to the administration of vitamin E ~ while 
in others, selenium was substantially more effective or induced an enhanced response. For 
example, white muscle disease in lambs is readily prevented by administering selenium to 
the ewe, whereas vitamin E is essentially ineffective. Limited placental transfer of vitamin 
E evidently is one factor in this difference in efficacy, since vitamin E is active when given 
to lambs directly in therapeutic doses. Selenium is not only more efficiently transferred 
across the placenta and secreted in the milk but is also more actively retained in the tissues 
of the young. There are inconsistent reports that administration of selenium induces 
increased growth in lambs receiving adequate vitamin E. On the other hand, selenium is 
not effective against other aspects of this syndrome, notably the susceptibility of 
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erythrocytes to hemolysis. Maximal overall response appears to depend on the presence 
of adequate amounts of both nutrients (Beeson et al., 1971; Vergroesen and Crawford, 
1989). 
At least a partial explanation for the relationship between selenium and vitamin E 
has been suggested by experiments on exudative diathesis in chicks. Like liver necrosis in 
rats, this disease has been induced by feeding a diet low in selenium, vitamin E, and 
protein (sulfur amino acids). It has been a general observation that these diseases can be 
prevented by administering either selenium or vitamin E. However, experiments indicate 
that when chicks are fed a diet extremely low in selenium (less than 0.005 ppm), vitamin E 
no longer prevents kidney degeneration and mortality even when given in high 
concentrations. Exudates only occur after the body stores of vitamin E have become 
depleted as a result of poor absorption of the vitamin. Under these conditions, the 
intestinal absorption of dietary lipids, including vitamin E, is severely inhibited. These 
observations suggest that selenium functions in the absorption of dietary vitamin E (Harik-
Khan et al., 1993; Beeson et al., 1971). 
Vitamin E is found in dark green vegetables, eggs, liver and other meats, wheat 
germ, vegetable oils, oatmeal, peanuts, and tomatoes. Selenium is found in food sources 
such as butter, wheat germ, apple cider vinegar, garlic, asparagus, smelt and other fish. 
Low-fat foods from the meat group, breads and cereals, and legumes are good sources of 
this vital mineral. However, because soil levels of this nutrient vary according to 
geographical region, eating a broad spectrum of the above foods may be advisable. 
Selenium deficient soils in China have been directly linked to Keshan disease, a 
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cardiomyopathy that is endemic in large areas of China. Keshan disease is especially 
harmful to young children in that it alters the normal development of the heart tissue 
(Weiner, 1986). 
Biological Mechanisms of Vitamin E and Selenium 
The biological interrelationship between vitamin E and selenium was elucidated by 
Rotruck et al. (1973) who showed selenium to be an integral part of the enzyme 
glutathione peroxidase. Vitamin E is a collective name for a group of closely related lipids 
called tocopherols, which are very important because of their antioxidant action in vitro 
(Combs et al., 1975). 
Selenium and vitamin E are both believed to act as antioxidants which function as 
one of the body's primary defenses against free radicals and reactive oxygen molecules 
(Combs et al., 1975; Bostick et al., 1993). Free radicals are formed naturally in our bodies 
during metabolic activity by the addition of electrons to oxygen molecules. Free radical 
formation can be increased by smoking, poor dietary habits, disease states or the normal 
processing of the oxygen we breath. Free radicals can react destructively with the cells 
and tissues of the body as a result of their oxygen toxicity. Antioxidants function by 
stabilizing volatile oxygen molecules (free radicals). Experts believe this "oxidative 
damage" contributes to many conditions including heart disease, cancer and even the basic 
process of aging (Barnett, 1995; Bostick et al, 1993). Free radicals and reactive oxygen 
molecules can initiate cell damage by reacting with unsaturated bonds in membrane lipids, 
denaturing proteins and altering nucleic acids (Bostick et al., 1993). 
Vitamin E is the major lipid-soluble antioxidant found in cell membranes. It 
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prevents per oxidative damage to the cell membrane by trapping free radicals and reactive 
oxygen molecules thus inhibiting their destructive action. Vitamin E is also important in 
the protection of the subcellular organelles from free radical damage (Nemec et al., 1990; 
Bostick et al., 1993). In addition, it can also stimulate the immune system and may 
protect against the development of cancer by enhancing immune surveillance. Vitamin E 
reduces nitrite, thereby inhibiting the production of compounds that have been shown to 
induce tumors in experimental animals and possibly in humans (Combs et al., 1975; 
Bostick et al., 1993; Greeder and Milner, 1980; Poirer and Milner, 1983; Medina et al., 
1983). 
Selenium has a biological function related to vitamin E in that selenium is an 
essential component of glutathione peroxidase (GSHPx), which is an enzyme involved in 
the detoxification of hydrogen peroxide and lipid hydroperoxides (Rotruck et at., 1973). 
Selenium is non-lipid soluble, and its protective action is found in the aqueous cytosol 
within the cell. The antioxidative role becomes very important during the immune 
response when neutrophils produce large quantities of superoxide and hydrogen peroxide 
(examples of free radicals) from molecular oxygen to destroy ingested foreign 
microorganisms. Antioxidants help to rid the body of the excess free radicals once their 
job of killing the foreign microorganisms is finished. The lymphocytes seem to be 
especially susceptible to peroxidative damage because their membranes have a relatively 
high free fatty acid content. Cellular membranes are involved in the transport of soluble 
substances and are also actively involved in the binding of mitogens and antigens (Nemec 
et al., 1990; Combs et al., 1975; Sheflfy and Schultz, 1979). 
1 1 
Vitamin E has been associated with a variety of functions affecting the 
reproductive, nervous, circulatory, muscular, skeletal, and hematopoietic cells (Shefify and 
Schultz, 1979). Clinical signs of deficiency are degenerative in nature and often involve 
the stability of biological membranes. Vitamin E is more often thought of as an 
antioxidant and free radical scavenger than in the development and function of the immune 
system. Vitamin E protects against dangerous blood clots and affects blood cholesterol 
levels, blood flow to the heart, strength of capillary walls, and muscle and nerve 
maintenance (Weiner, 1986; Sheffy and Schultz, 1979). 
The antioxidant protection of selenium may become defective during 
sickness, malnutrition, and old age. This decline in antioxidant activity may result in 
impaired cell function which could cause weakened immunity and overall a poorer state of 
health. With advancing age, the glutathione peroxidase-selenium enzyme does not work 
as efficiently and noxious oxidants accumulate in the body (Desowitz, 1987). 
Selenium is extremely valuable for treating poisoning with heavy metals, such as 
mercury and cadmium, since it facilitates their excretion from the body. These toxic heavy 
metals have immunosuppressive effects on the body. However, too much selenium can 
also be dangerous. Weiner (1986) reported that in high doses selenium can produce 
symptoms such as loss of hair, nails, dizziness, fatigue, and dermatitis. However, he noted 
that in some cases high-dose supplementary selenium was tolerated over long periods 
without toxicity (Weiner, 1986). 
Selenium, Vitamin E and The Immune System 
In 1973, the accepted nutritionally adequate dietary level for selenium was 0.1 
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ppm. Selenium is less toxic in biological systems if given as a sodium salt of selenium 
(Na2Se03). Spallholz et al. (1973) supplemented mice with dietary selenium in the range 
of 0.75 ppm to 10 ppm. Most of the mice were also supplemented with 70 ppm vitamin E 
or DL-a-tocopherol acetate. Included in the study was a selenium-toxic diet for a group 
of mice that were fed 14 ppm selenium for two weeks and 42 ppm selenium for three 
weeks. The highest anti-sheep red blood cell antibody levels were found in mice given the 
0.7 ppm and 2.8 ppm of selenium. The conclusion of that study was that dietary selenium 
at levels above that generally accepted as nutritionally adequate enhances the primary 
immune response in mice by increasing the numbers of plaque forming cells and antibody 
levels. Those authors reported that dietary selenite promoted immunoglobulin M (IgM) 
synthesis while vitamin E promoted immunoglobulin G (IgG) synthesis (Spallholz et al., 
1973). 
Vitamin E has been implicated in the stimulation of serum antibody synthesis, 
particularly IgG antibodies (Tengerdy et al., 1972, Tengerdy et al., 1973). Heinzerling et 
al. (1974a) collaborated with Tenderdy on a later study in which mice were supplemented 
with 180 milligrams of vitamin E (DL-a-tocopheryl acetate) per kilogram of food. The 
mice were challenged with Diplococcus pneumoniae type I, and the phagocytic activity 
against this bacterial strain was measured. The phagocytic index of mice that had been 
immunized prior to being challenged with Diplococcus pneumoniae was four times higher 
in the 180 mg/vitamin E group than in a control group of infected mice. The results of 
that study indicated that increased macrophage activity probably aided by increased 
antibody production was the principal reason for the increased protection. Heinzerling et 
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al. (1974b) completed another study of vitamin E with chicks exposed to Escherichia coli. 
Supplemental dietary vitamin E of 150-300 mg/kg provided enhanced protection and 
immunity to the chicks. Yasunaga et al. (1982) reported that vitamin E can significantly 
enhance immune responses to the mitogens: phytohemagglutin, concanavalin A, and 
lipopolysaccharide. 
An enhancing effect of vitamin E on antibody production by activation of the 
humoral immune system was observed in lambs challenged with parainfluenza virus. It 
was reported from this study that although the IgM antibody levels increased more 
substantially in selenium supplemented animals, the increase was greater with vitamin E 
supplemention after a secondary antigenic challenge (Reffert et al., 1988). 
Interleukin-1 (IL-1), a cytokine primarily produced by activated monocytes and/or 
macrophages after antigenic challenge, is capable of activating T cells during antigen 
presentation, inducing IL-2 receptor expression by T helper cells, and enhancing B cell 
proliferation (Chandra, 1992; Corwin and Shloss, 1980). 
The research work of Romach et al. (1993) lends support to the theory that vitamin E can 
enhance the immune response in both cellular and humoral immunity. Vitamin E 
supplementation has been shown to enhance immunity by inducing macrophages to 
produce elevated levels of EL-1 and/or by down-regulating other immune factors that 
would inhibit the production of IL-1 (Romach et al., 1993). 
In a double-blind, placebo-controlled study, Meydani et al. (1990) showed 
that supplementation of healthy elderly subjects, over 60, with vitamin E (800 IU/day of 
DL-a-tocopheryl acetate) for 30 days significantly improved delayed type hypersensitivity 
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(DTH) responses, lymphocyte proliferative responses to the T cell mitogen, concanvalin 
A, and concanavalin A stimulated IL-2 production. Furthermore, supplementation with 
400 IU/day of vitamin E for six months produced a 91% increase in the DTH response of 
healthy elderly individuals. It was concluded from these studies that the improvements 
observed following short-term supplementation with vitamin E are maintained during 
longer periods of supplementation and that a dose of 400 IU/day of vitamin E is effective 
in inducing these changes. Vitamin E and selenium were both included in this study 
because they play a regulatory role in the immune response; however, the effect of 
selenium was not emphasized in this study (Meydani et al., 1990). Meydani (1993) 
proposed that vitamin and mineral supplementation exceeding the recommended dietary 
allowance significantly improves certain indices of the immune response in the elderly. 
The results of Chandra (1992) agreed with the above findings and showed that 
immunological improvements following nutrient supplementation were associated with 
decreased frequency of infection-related illnesses in the elderly. 
Moriguchi et al. (1993a) examined the effect of vitamin E supplementation on 
cellular immune functions that decreased with age. Their study used spontaneously 
hypertensive rats which were divided into two groups, one which was fed a 50 mg vitamin 
E/kg diet and the other which was fed a 585 mg vitamin E/kg diet. Spontaneously 
hypertensive rats represent accelerated disease and abnormality of cellular immune 
functions associated with aging (Moriguchi et al., 1993a). This research group reported 
that high vitamin E diets could enhance both splenic lymphocyte and alveolar macrophage 
functions in rats. The T cell functions appeared to be greatly affected by vitamin E 
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deficiency, and it was concluded that vitamin E plays an important role in T cell 
differentiation in the thymus (Moriguchi et al., 1993a). 
Another study by Moriguchi et al. (1993b) demonstrated the effects of vitamin E 
on the differentiation of T cells in the thymus by monitoring the proportions of CD4+CD8~ 
and CD4"CD8+ T cells and evaluated a possible association between the effect of vitamin E 
on T cell differentiation in the thymus and the action of vitamin E as an antioxidant. The 
F344 rats were divided into three groups: vitamin E-free diet, normal diet (50 mg vitamin 
E) and high vitamin E diet (585 mg vitamin E). The results for the vitamin E-free group 
and the high vitamin E group were compared to results obtained for the normal 50 mg 
vitamin E group. The number of thymocytes was significantly lower in the vitamin E-free 
group compared to the normal group. The ratio of CD4+CD8YCD4"CD8+ T cells in the 
spleen increased in the high vitamin E group and significantly decreased in the vitamin E-
free group. Production of IL-2 by thymocytes following stimulation with concanavalin A 
for 48 hours increased approximately three-fold in the high vitamin E group. 
Prostaglandin E2 production from thymocytes was significantly lower in the high vitamin 
E group compared to the normal group of rats. These results of Moriguchi et al. (1993b) 
suggested that vitamin E plays an important role in T cell differentiation in the thymus, 
which may be related to the action of vitamin E as an antioxidant. 
Deficiencies of vitamin E and/or selenium have been shown to cause suppression 
of the immune system in small mammals. Both humoral and cellular immune responses are 
enhanced by vitamin E and selenium supplementation (Wuryastute et al., 1993). The 
purpose of the present study was to determine the effect of elevated levels of vitamin E 
and/or selenium on the immune response of mice following antigenic challenge with a 
lethal dose of T. cruzi. Parasitemia, antibody production and mortality were measured 
an effort to determine how each of these parameters would be affected by dietary 
supplementation with the antioxidants, vitamin E and selenium. 
MATERIALS AND METHODS 
Parasites 
The Brazil strain of T. cruzi was used throughout this research project. The 
parasites were maintained by stock infections in C3HeB/FeJ mice in the blood-form 
trypomastigote stage (BFT). An infection inoculum of 1 x 103 BFT'S in 0.2 ml of 
Dulbecco's phosphate buffered saline (DPBS, Sigma Chemical Co., St. Louis, Mo.) was 
administered intraperitoneally (IP) to each mouse. 
Mice 
Syngeneic female mice, strain C3HeB/FeJ (Jackson Laboratories, Bar Harbor, 
Maine), were maintained at room temperature (26°C) in accordance with NTH and local 
IACUC guidelines. The mice were four-five weeks old (born 4/2/94 and 4/3/94) upon 
arrival and were immediately switched to the synthetic food. Food and tap water were 
provided ad libitum. Age matched female mice that were fed a common Purina rodent 
chow, # 5001 (Purina, Richmond, IN ), served as the infected control mice. The 
nutritionally adequate amount in Purina rodent chow # 5001 fed to infected control mice 
was 0.2 ppm of selenium and 49 IU/kg of vitamin E (Purina, 1994). Strain C3HeB/FeJ 
mice are highly susceptible to infection with T. cruzi and death is normally expected by 
day 35 after the mice are injected IP with an infection inoculum of 1 x 103BFT. Three 
identical trials of mice, Trial # 1, Trial # 2 and Trial # 3, were set up with four cages per 
trial for research in this order: 
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Cage A: Vitamin E and Selenium Deficient, n=8 
(Trial # 2 = 4 mice, Trial # 3 = 5 mice) 
Cage B: 2 ppm Selenium, n = 9 
(Trial # 2 = 4 mice, Trial # 3 = 5 mice) 
Cage C: 800 IU/kg Vitamin E plus 2 ppm Selenium, n = 9 
(Trial # 2 = 4 mice, Trail # 3 = 5 mice) 
Cage D: 800 IU/kg Vitamin E, n = 10 
(Trail # 2 = 5 mice, Trial # 3= 5 mice) 
Cage E: Control Mice fed a common Purina Rodent Chow, # 5001, n = 3 
(71 cruzi infected control mice ) 
A third trial, Trial # 1, consisting of 20 mice was set up with 4 cages of 5 mice 
each. Cages A, B, C, and D were fed the synthetic diets in the same order as in the other 
2 trials. The mice in Trial # 1 showed very few numbers of parasites in the peripheral 
circulation up through day 70 of the study due to an air conditioning malfunction. There 
was a substantial increase in temperature during several weeks at the start of the research. 
It has been documented by other research studies that a temperature increase can alter the 
course of experimental Chagas' disease. When maintained at an elevated temperature of 
36 C, infected mice show low parasitemia and low mortality as compared to mice 
maintained at room temperature (26° C), (Ming, 1994). The elevated temperature altered 
the normal course of Chagas' disease in Trial # 1; therefore, these results are not included 
in the study. 
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Diets 
Purified synthetic diets were prepared by Purina Test Diet Department in 
Richmond, Indiana. See Table 1 for diet formulations and Table 2 for diet specifications 
for the vitamin E and selenium purified diets. 
Diet # 1: Vitamin E Deficient / Selenium Deficient 
Diet #2: 800 IU/kg Vitamin E / Selenium Deficient 
Diet # 3: Vitamin E Deficient / 2 ppm Selenium 
Diet #4: 800 IU/kg Vitamin E / 2 ppm Selenium 
ELISA (Enzyme linked immunosorbent assay) 
A detergent extract of fibroblast-derived trypomastigotes (FDTS; 10 ug/ml 
concentration) was used as the source of antigen in 96 well microtiter plates. The mice 
were bled starting at day 20 and continued at 3-4 day intervals thereafter. Twenty ul 
(microliters) of blood were drawn from each mouse via a tail vein and diluted in 80 ul of 
DPBS. Diluted blood was then centrifuged for 10 min. at 8,000 revolutions per min. 
(rpm), and the diluted plasma was removed and stored at -20°C until batch testing could 
be performed at a later date. The mouse plasma, which contained the anti-T. cruzi 
antibody, was used as the primary antibody in the 96 well ELISA plates. Plasma samples 
for each mouse within the same synthetic diet treatment cage were pooled. Two-fold 
serial dilutions of the mouse plasma were prepared in duplicate for each sample of pooled 
mouse plasma. The secondary antibody was goat anti-mouse immunoglobulin conjugated 
to horseradish peroxidase (HRP) (Fisher Diagnostics, Pittsburgh, Pa.). The substrate, O-
phenylene-diamine (Sigma) was dissolved in Tris-citrate buffer and activated with 30 % 
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DIET FORMULATIONS 
Ingredients Diet #1 Diet #2 Diet #3 Diet #4 
Vitamin Free Casein (92% Protein) 21% 21% 21% 21% 
Sucrose 15 15 15 15 
Solka Floe (non-Nutritive fiber) 3 3 3 3 
Vitamin mix without Vitamin E 2.00 2.00 2.00 2.00 
Mineral Mix without Selenium 5.00 5.00 5.00 5.00 
DL-Methionine 0.15 0.15 0.15 0.15 
Choline Chloride 0.20 0.20 0.20 0.20 
Tocopherol Stripped Lard 5.00 5.00 5.00 5.00 
Tocopherol Stripped Corn Oil 5.00 5.00 5.00 5.00 
Dl-fl-tocopherol Acetate (Vitamin E 50%) — 0.16 — 0.16 
Sodium Selenite (45.66% Se) — — 0.00044 0.00044 
Dextin (Cornstarch) 43.65 43.49 43.64956 43.48956 
TOTALS 100.0% 100.0% 100.0% 100.0% 
Table 1. The four pelleted, synthetic diets formulated by Purina consist of the 
following: Diet # 1 contains 0 vitamin E /0 selenium, Diet # 2 contains 800 IU/kg 
Vitamin E / 0 selenium, Diet # 3 contains 0 vitamin E / 2 ppm selenium and Diet # 
4 contains 800 IU/kg Vitamin E / 2 ppm selenium. 
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DIET SPECIFICATIONS 
Diet Specifications * Diet # 1 Diet # 2 Diet # 3 Diet # 4 
Protein % 19.32 19.32 19.32 19.32 
Fat % 10.00 10.00 10.00 10.00 
Fiber % 4.29 4.29 4.29 4.29 
Carbohydrate % 60.55 60.55 60.55 6 0 . 5 5 
Digestible Energy (KCal/Gm) 4.09 4.09 4.09 4.09 
Vitamin E IU/KG < 10.00 800.00 < 10.00 800.00 
Selenium ppm <0.035 < 0.035 2.00 2.00 
Table 2. Diet specifications for the four pelleted, synthetic diets. * Synthetic Diet 
Food was stable for six months when stored in the refrigerator under cool and dry 
conditions. 
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Hydrogen Peroxide (H2O2). The optical densities in each well of the ELISA plates were 
measured with a Microplate reader (Courtesy of Vanderbilt University). The optical 
densities measured at 450 nm were plotted against the reciprocal of the dilutions. 
Parasite-specific antibody titers were determined from these plotted data. The parasite-
specific antibody titer was calculated as the highest dilution that remains greater than + 2 
SD from the absorbance of the noninfected normal mouse serum. 
Monitoring Parasitemia and Mortality 
Parasitemias were determined at three to four day intervals starting at day 13 post-
infection. Blood was obtained from the infected mice by clipping the tip of the tail and 
squeezing the tail until a uniform round drop of blood was expelled. Four ul of the 
infected mouse blood were collected and added to 96 ul DPBS which constituted a 1/25 
dilution. A well mixed aliquot of the 1/25 dilution was placed on a hemacytometer 
counting chamber and the number of parasites in 4 large corner squares was counted. The 
calculation used was [average # parasites/1 large square x reciprocal of the dilution factor 
(25) x reciprocal of the volume of 1 large square (104) = BFT /ml blood]. Calculations 
were made to determine BFTs per ml of peripheral blood. Data were collected using this 
procedure until the parasites were consistently not seen in the circulating blood from mice 
that survived the entire length of the research study. Mice were also monitored daily for 
clinical symptoms and mortality. 
Statistical Analysis 
All statistical analyses were performed using SYSTAT, Version 5.1 (Wilkinson, 
1992). To check for normality of data distributions (data = parasitemia values for the 
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individual mice and the optical density (OD) of the antibody levels), Kolmogorov-Smirnov 
tests, Lilliefor's option, were performed within treatment trials. Both the parasitemia and 
optical density values were shown not to be normally distributed (p < 0.05). As values 
spanned several orders of magnitude, parasitemia and OD measurements were log 
transformed to restore linearity (Wilkinson, 1992). 
To examine the relationship between antibody levels and parasitemias, the 
correlation coefficient was computed on the log-transformed data across all treatment 
cages. Due to lack of normality likely resulting from the pooling of treatment cages, the 
Spearman correlation coefficient was used (Wilkinson, 1992). 
The possibility of pooling replicate treatment cages in the two trials was examined 
by regressing the parasitemia and antibody levels against the time period of infection using 
a least squares model. The differences between the slopes and intercepts of the best fit 
lines from replicate cages were then compared. There were no statistically significant 
differences detected for the replicate treatment cages in Trials # 2 and # 3, means ±2 SE 
overlapped for 8 of 8 pairs of intercepts and 7 of 8 pairs of slopes, indicating that the 
replicate treatment cages in the two trials could be combined for subsequent analysis 
(Wilkinson, 1992). 
Significance of the relationship between the four different synthetic diet treatments 
was assessed using ANCOVA. Slopes were homogeneous across all treatment cages (p > 
0.05). Since the assumption of homogeneity of slopes was satisfied in all cases, intercept 
differences between the cages of mice fed synthetic food were tested for significance using 
ANCOVA. To determine which cages differed significantly, pairwise comparisons were 
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made for the pooled treatment cages (A, B, C, D) using the conservative Tukey's HSD 
Multiple Comparison Test. This test corrects for Type I error level when multiple tests 
are being applied (Wilkinson, 1992). 
RESULTS 
Determination of Parasitemia 
Figure 2 shows the mean parasitemias for the replicate pooled cages of mice in 
Trials # 2 and # 3 in comparison to the infected control mice. The mean peak parasitemia 
of all the mice fed synthetic food was 2.56 x 106 parasites / ml of blood compared to 1.12 
x 107 parasites / ml of blood for the infected control mice. The mean peak parasitemia for 
the mice fed synthetic food was fourfold lower than the mean peak parasitemia of the 
infected control mice. The mice that received the 800 IU/kg vitamin E had the lowest 
overall mean peak parasitemia of 1.26 x 106 parasites / ml of blood, which represents a 
ninefold lower mean peak parasitemia when compared to the infected control mice. The 
mean peak parasitemia of mice for the replicate treatment cages in Trials # 2 and # 3 were 
as follows: Cage A = 3.07 x 106 parasites / ml of blood (threefold lower than infected 
control mice), Cage B = 2.41 x 106 parasites / ml of blood (fourfold lower than infected 
control mice), Cage C = 3 .48 x 106 parasites / ml of blood (threefold lower than infected 
control mice), Cage D = 1.26 x 106 parasites / ml of blood (ninefold lower than infected 
control mice) and Cage E (infected control mice) = 1.12 x 107 parasites / ml of blood. 
Parasitemia levels showed significant differences among cages over time. The 
rates of increase in parasite numbers were heterogeneous among cages (cage x day 
interaction was significant; F4;276 = 9.755, p < 0,001). The T. cruzi infected control mice 
had a significantly higher slope than all synthetic treatment cages (slope means + 2 SE did 
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Parasitemia 
Figure 2. Parasitemia 
Mean parasitemias of the pooled, replicate synthetic diet treatment cages in Trials # 2 and 
# 3 are shown versus days post-infection. Cage E represents T. cruzi infected control 
mice fed Purina rodent chow #5001. Parasitemias are shown up to day 44 post-infection, 
which is the day that the number of blood-form trypomastigotes peaked in the peripheral 
blood. Cage A represents mice fed diets containing 0 vitamin E / 0 selenium (n = 8), Cage 
B represents mice fed diets containing 0 vitamin E / 2 ppm selenium (n = 9), Cage C 
represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium (n = 9), Cage 
D represents mice fed diets containing 800 IU/kg Vitamin E / 0 ppm selenium (n = 10) and 
Cage E represents T. cruzi infected control mice (n = 3). 
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Parasitemia 
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not overlap). Among the four different diet treatments, Cage B had a significantly greater 
slope than did Cage D. None of the other five comparisons were significant. 
Parasite-specific Antibodies 
Parasitemia and the anti-71. cruzi antibody levels were significantly 
positively correlated across all days and treatment trials (Spearman correlation = 0.7, n = 
228, p < 0.001). High parasitemia values were associated with high anti-7'. cruzi antibody 
levels. 
Significant differences in antibody levels over time were detected among certain 
treatment cages. The assumption of homogeneity of slopes was satisfied for all treatments 
(cage x day interaction was nonsignificant: F3;29i = 0.399, p = 0.754). Tests for intercept 
differences using ANCOVA showed that there was a significant treatment effect on 
antibody levels (F3,294 = 9.894, p < 0.001). Pairwise comparisons of the four cages by 
Tukey's HSD multiple comparisons test indicated that mice in Cages A and B were not 
significantly different from each other; similarly, mice in Cages C and D were not 
significantly different. However, mice in Cages A and B were significantly different from 
mice in Cages C and D (Table 3). 
All of the infected mice receiving synthetic food diets showed increases in antibody 
levels throughout the acute phase of the infection. Death by day 46 of the infected control 
mice marked the end of the acute phase for all the mice in the study. Figures 3, 4, 5 and 6 
show the anti-71. cruzi antibody levels measured by ELISA. Days shown post-infection 
are 20, 35, 44 and 53. Cage G is representative of a noninfected normal mouse serum. 
Plasma from mice in the non-infected control cage served as the baseline to detect 
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Tukey's HSP Multiple Comparisons 
A B c D 
A 0.037 -0.219 - 0.273 
B 0.953 -0.256 -0.310 
C 0.011 0.002 - 0.054 
D 0.001 0.000 0.866 
Table 3. Tukey's HSD comparisons tests for significant pairwise differences among 
synthetic diet treatments. Values obtained above are based on parasite-specific antibody 
levels. The values above the diagonal are pairwise mean differences and those below the 
diagonal are associated probabilities. Probabilities less than 0.05 are considered 
significant. Data are pooled across replicate diet treatment cages in Trials # 2 and # 3. 
For example, the pairwise mean difference between Cages A and D was - 0.273 which 
corresponds to an associated probability of 0.001, indicating significant differences 
between Cages A and D. Cage A represents mice fed diets containing 0 vitamin E / 0 
selenium, Cage B represents mice fed diets containing 0 vitamin E / 2 ppm selenium, Cage 
C represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium and Cage D 
represents mice fed diets containing 800 IU/kg vitamin E / 0 selenium. 
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increasing antibody titers. 
Mortality 
By day 70, percent survival for mice in the replicate treatment cages in Trials # 2 
and # 3 was as follows: Cage A = 37.5%, CageB= 44.5%, Cage C = 77.8%, and 
Cage D = 80.0%. The infected control mice, Cage E, fed Purina rodent chow #5001, 
exhibited 0% survival by day 46 (See Figure 7). Cage A represents 0 vitamin E / 0 
selenium, Cage B represents 0 vitamin E / 2 ppm selenium, Cage C represents 800 IU/kg 
vitamin E / 2 ppm selenium and Cage D represents 800 IU/kg vitamin E / 0 selenium. The 
mice supplemented with diets containing 800 IU/kg vitamin E had approximately twice the 
number of survivors compared to mice supplemented with diets that were deficient in 
vitamin E. There was an overall synthetic food enhancement effect which is shown by the 
high percent survival (37.5 %) of mice supplemented with diets deficient in vitamin E and 
selenium. Death is normally expected by day 35 post-infection with C3HeB/FeJ mice used 
in the present study. 
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Parasite-specific Antibody Levels/ Day 20. 
Figure 3. Parasite-specific antibody levels on day 20 post-infection. Using a parasite-
specific ELISA, levels of mXi-T.cruzi antibodies were measured in pooled plasma samples. 
Twofold serial dilutions were tested for the presence of parasite-specific antibodies in the 
ELISA microtiter plates. Pooled replicate cages are represented by Cages A, B, C and D. 
Cage A represents mice fed diets containing 0 vitamin E / 0 selenium (n=8), Cage B 
represents mice fed diets containing 0 vitamin E / 2 ppm selenium (n=9), Cage C 
represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium (n=9), Cage D 
represents mice fed diets containing 800 IU/kg vitamin E / 0 selenium (n=10) and Cage G 
represents noninfected normal mouse serum from mice fed Purina rodent chow # 5001 
(n=5). 
Parasite Antibodies: Day 20 
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Parasite-specific Antibody Levels / Day 35 
Figure 4. Parasite-specific antibody levels on day 35 post-infection. Using a parasite-
specific ELISA, levels of anti-71. cruzi antibodies were measured in pooled plasma 
samples. Twofold serial dilutions were tested for the presence of parasite-specific 
antibodies in the ELISA microtiter plates. Pooled replicate cages are represented by 
Cages A, B, C and D. Cage A represents mice fed diets containing 0 vitamin E / 0 
selenium (n=8), Cage B represents mice fed diets containing 0 vitamin E / 2 ppm selenium 
(n=9), Cage C represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium 
(n=9), Cage D represents mice fed diets containing 800 IU/kg vitamin E / 0 selenium 
(n=10) and Cage G represents noninfected normal mouse serum from mice fed Purina 
rodent chow # 5001 (n=5). 
Parasite Antibodies: Day 20 
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Parasite-specific Antibody Levels / Day 44. 
Figure 5. Parasite-specific antibody levels on day 44 post-infection. Using a parasite-
specific ELISA, levels of anti-71. cruzi antibodies were measured in pooled plasma 
samples. Two fold serial dilutions were tested for the presence of parasite-specific 
antibodies in the ELISA microtiter plates. Pooled replicate cages are represented by 
Cages A, B, C and D. Cage A represents mice fed diets containing 0 vitamin E / 0 
selenium (n=8), Cage B represents mice fed diets containing 0 vitamin E / 2 ppm selenium 
(n=9), Cage C represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium 
(n=9), Cage D represents mice fed diets containing 800 IU/kg vitamin E / 0 selenium 
(n=10) and Cage G represents noninfected normal mouse serum from mice fed Purina 
rodent chow # 5001 (n=5). 
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Parasite-specific Antibody Levels / Day 53. 
Figure 6. Parasite-specific antibody levels on day 53 post-infection. Using a parasite-
specific ELISA, levels of anti-7! cruzi antibodies were measured in pooled plasma 
samples. Twofold serial dilutions were tested for the presence of parasite-specific 
antibodies in the ELISA microtiter plates. Pooled replicate cages are represented by 
Cages A, B, C and D. Cage A represents mice fed diets containing 0 vitamin E / 0 
selenium (n=8), Cage B represents mice fed diets containing 0 vitamin E / 2 ppm selenium 
(n=9), Cage C represents mice fed diets containing 800 IU/kg vitamin E / 2 ppm selenium 
(n=9), Cage D represents mice fed diets containing 800 IU/kg vitamin E / 0 selenium 
(n=10) and Cage G represents noninfected normal mouse serum from mice fed Purina 
rodent chow # 5001 (n=5). 
Parasite Antibodies: Day 20 
Reciprocal Dilution 
- - • - - C a g e A —o—Cage B —x—CageC -x Cage D — • — C a g e G 
3 9 
Mortality. 
Figure 7. Percent survival for the pooled, replicate synthetic diet treatment cages plus the 
T. cruzi infected control mice fed Purina rodent chow # 5001. Results shown are the 
combination of the pooled replicate treatment cages in Trials # 2 and # 3. Cage A 
represents mice fed diets containing 0 vitamin E / 0 selenium (n =8), Cage B represents 
mice fed diets containing 0 vitamin E / 2 ppm Selenium (n = 9), Cage C represents mice 
fed diets containing 800 IU/kg Vitamin E / 2 ppm selenium (n = 9), Cage D represents 
mice fed diets containing 800 IU/kg Vitamin E / 0 selenium (n= 10) and Cage E represents 
T. cruzi infected control mice fed Purina rodent chow, # 5001 (n = 3). 
MORTALITY 
Days Post-Infection 
—•--—Cage A —o—Cage B —*—CageC - x Cage D —•—Cage E 
DISCUSSION 
If Chagas' disease could be effectively controlled by using natural vitamins or 
minerals, the implication in endemic areas of Latin America would be tremendous. 
Although Chagas' disease is endemic in Central and South America, there is a potential 
worldwide problem with the parasitic infection as individuals emigrate to new areas. 
Considering that the majority of infected individuals are asymptomatic and unaware they 
are infectious, the importance of an adequate therapeutic approach to Chagas' disease 
should be apparent. 
As mammalian hosts have evolved new defense strategies to rid themselves of 
parasitic protozoans, the protozoans themselves have also co-evolved strategies to allow 
survival in their host. The protozoan parasite, T. cruzi, has developed several strategies to 
evade the immune response and survive in the mammalian host for an extended period of 
time in which the parasites can cause extensive damage to their host. Ultimately, the 
success of this research could make vitamin E and selenium effective tools to aid the 
immune response in the battle against Chagas' disease. To the author's knowledge, this is 
the first study designed to evaluate the effect of dietary antioxidants on Chagas' disease. 
The results of the present study demonstrate that increased dietary intake of 
vitamin E can have a positive impact on the course of experimental Chagas' disease. Mice 
supplemented with synthetic diets containing 800 IU/kg vitamin E had the lowest overall 
parasitemia levels and also the highest percent survival. These mice had a ninefold lower 
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mean peak parasitemia level (1.26 x 106 parasites / ml of blood) than the infected control 
mice (1.12 x 107 / ml of blood). Eighty percent of the mice supplemented with synthetic 
diets containing 800 IU/kg vitamin E survived to day 70 post-infection compared to only 
37.5% survival in the mice supplemented with synthetic diets deficient in vitamin E and 
selenium. 
The combined mean peak parasitemia levels for all mice fed synthetic diets (2.56 x 
106 parasites / ml of blood) was fourfold lower than the infected control mice (1.12 x 107 
parasites / ml of blood). After the mice supplemented with synthetic diets had peaked in 
their parasitemia by day 44, there was a gradual decline in circulating blood-form 
trypomastigotes until none were evident in the peripheral circulation. The mice 
supplemented with synthetic diets also did not exhibit the typical sharp rise in parasitemias 
that was exhibited by the infected control mice. Furthermore, the peak in parasitemia for 
the infected control mice coincided closely with the days of their death. By day 46 post-
infection, all of the T. cruzi infected control mice were dead. 
Mice supplemented with synthetic diets containing 800 IU/kg vitamin E plus 2 
ppm selenium developed higher parasitemia levels (3 .48 x 106 parasites / ml of blood) than 
the mice supplemented with dietary 800 IU/kg vitamin E only (1.26 x 106 parasites / ml of 
blood). One mouse in the replicate cages fed the synthetic diet containing 800 IU/kg 
vitamin E plus 2 ppm selenium developed extremely high parasitemia levels that were 
sixfold higher than any of the other mice in the same representative cages. 
Mice supplemented with synthetic diets containing 800 IU/kg vitamin E had an 
80% survival by day 70 post-infection which was the highest percent survival of all the 
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mice. Mice supplemented with 800 IU/kg vitamin E plus 2 ppm selenium had the next 
highest percent survival of 77.8% by day 70 post-infection. These percent survival are 
relatively close and are representative of four cages of mice. The remaining mice 
supplemented with the other two synthetic diets showed a much lower combined percent 
survival of 41%. Therefore, there were approximately twice the number of survivors 
among the mice supplemented with diets containing an elevated level of vitamin E as 
compared to mice fed synthetic diets deficient in vitamin E. Mice supplemented with 
synthetic diets containing 2 ppm selenium exhibited 44.5% survival which is close to the 
37.5% survival of the mice fed diets deficient in vitamin E and selenium. The percent 
survival of the infected control mice was 0% by day 46 post-infection. The death of all 
the infected control mice by day 46 marked the approximate end of the acute phase of the 
infection and the movement of the survivors into the chronic phase of the infection. 
The C3HeB/FeJ mice used in this study are highly susceptible to T. cruzi infection 
and death is normally expected by day 35 post-infection. The death of the last infected 
control mouse by day 46 post-infection is suggestive of a decrease in virulence in the J! 
cruzi strain used in this study. The high percentage of survivors in this study suggests that 
dietary supplementation with increased levels of antioxidants can enhance the immune 
response of mice to Chagas' disease. The mouse model shares many similarities with 
human Chagas' disease; and therefore, the results of this study suggest that antioxidants 
may also improve the human response to Chagas' disease. 
In this research many of the mice that survived did not exhibit the classic Chagas' 
disease anemia evidenced by a decrease in the circulating red blood cells. Profound 
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anemia was shown by the mice that died by evidence of the low percentage of red blood 
cells present in the hemacytometer counts. The majority of the surviving mice that were 
supplemented with synthetic diets remained active during the acute and chronic phase of 
infection and did not exhibit any classic pathological symptoms that are normally 
associated with this strain of mice. Further studies are needed to determine the numbers 
of amastigotes present in tissue samples of the mice supplemented with synthetic diets as 
compared to tissue amastigotes present in unsupplemented control mice. Histological 
studies would provide a more complete picture of the tissue pathology that allowed the 
mice supplemented with synthetic diets to survive and develop lower parasitemias than 
mice fed the commonly used Purina rodent chow # 5001 during the course of Chagas' 
disease. 
Vitamin E and selenium have been shown to enhance the immune system in a 
variety of ways. The synergistic effect vitamin E and selenium have on cells is essential 
for their ability to function optimally. Protection of cells against membrane damage 
resulting from uncontrolled lipid peroxidation depends upon the presence of vitamin E 
(Combs et al., 1975). The function of vitamin E and selenium in the maintenance of 
erythrocyte membrane integrity is vital since vitamin E is present within the membrane 
itself and selenium is associated primarily with the aqueous phase of the plasma membrane 
(Combs et at., 1975; Sheffy and Shultz, 1979). Erythrocytes and lymphoid cells originate 
from common pluripotential stem cells. This fact provided a basis for the concept that 
vitamin E and selenium may be associated with membrane fluidity of lymphoid cells, thus 
affecting immune response mechanisms as well (Sheffy and Shultz, 1979). Increased 
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intake of antioxidants like vitamin E and selenium, during stress or illness, may prove to be 
beneficial to overall health (Reffert et al., 1988). 
After an extensive literature search, Desowitz and Barnwell's research study 
(1980) was the only one found that addressed the antioxidant enhancement effect of 
selenium or vitamin E on mice challenged with a parasitic infection. The parasite used was 
the malarial parasite, Plasmodium berghei, which dramatically affects the red blood cell 
population of the host. These authors demonstrated that 2.5 ppm selenium can potentiate 
the protective effect of a killed Plasmodium berghei vaccine for Swiss-Webster mice 
(Desowitz and Barnwell, 1980), 
Sheflfy and Shultz (1979) concluded that the dietary levels of vitamin E and 
selenium most effective for immune response enhancement were those 10-30 times the 
dietary requirement, levels considered to be toxic for several mammalian species. Their 
research involved the measurement of antibody titers in dogs following vaccination with a 
canine distemper-hepatitis vaccine. The measurable antibody after immunization was 
depressed in the vitamin E and selenium deficient dogs. 
High doses of vitamin E has been shown to enhance phagocytosis and to increase 
humoral antibody production against particulate and soluble antigens in various animal 
species (Vergroesen and Crawford, 1989; Marsh et al., 1981). Corwin and Schloss 
(1980) showed that cell-mediated immune functions were also stimulated by high dietary 
levels of vitamin E in research animals. Vitamin E deficiency has been shown to result in 
decreased lymphatic organ size, T and B cell proliferation, white blood cell function, 
inflammatory response, and host resistance to infection (Weiner, 1986; Unanue and Allen, 
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1987). The research work of these authors is suggestive that elevated doses of vitamin E 
can play a part in immune system enhancement. 
In the present study, it was expected that the mice receiving synthetic diets 
deficient in vitamin E and selenium would exhibit 0% survival. However, these mice had a 
higher than expected percent survival of 37.5%. In addition, parasitemia levels were 
threefold lower in these mice than in the infected control mice fed Purina rodent chow # 
5001. These parasitemia levels and percent survival results led to the conclusion that all 
the mice on the four synthetic diets had an overall enhancement effect that had to be taken 
into consideration. Technical personnel at Purina Test Diet Department in Richmond, 
Indiana, were consulted concerning the synthetic rodent chow. Purina reported that the 
synthetic rodent chow had a higher absorption rate than the commonly used Purina rodent 
chow # 5001 (personal communication, 1994). In essence, the mice on the synthetic food 
were possibly more efficient in the uptake of vitamins and minerals from their food than 
were the mice on Purina rodent chow # 5001. Statistical analysis on the SYSTAT 
Version 5 .1 allowed for the elimination of the synthetic food effect so that the four 
different diet treatments could be compared to each other. 
Slopes of the plotted lines using parasitemias versus cage x day post-infection 
showed a significant difference between all synthetic diet treatment cages (A-D) and the T. 
cruzi infected control mice. The parasitemias of the infected control mice increased 
steadily until death resulted by day 46 post-infection. 
The correlation analysis showed a positive Spearman computation between the 
parasitemias and OD of the antibody levels, indicating that as the number of circulating 
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parasites increased the antibody levels also increased. Intercept differences of the OD of 
the antibody levels among all synthetic diet treatment cages were analyzed by ANCOVA 
and indicated a different response among one or more of the cages. The results of the 
parasite-specific antibody levels measured by ELISA showed an increase in antibody levels 
during the course of the parasitic infection. By day 20 post-infection, there were no 
measurable parasite-specific antibodies detected in plasma from mice in replicate cages in 
Trials # 2 and #3. By day 35 post-infection, plasma from infected mice supplemented 
with synthetic diets showed parasite-specific antibody titers greater than 1/512. These 
antibody titers remained high in all infected mice supplemented with synthetic diets 
throughout the course of infection. There were no obvious differences detectable for the 
rise in antibody levels between replicate cages of infected mice supplemented with 
synthetic diets in Trials # 2 and # 3 (See Figures 3,4, 5 and 6). This lack of obvious 
differences in antibody levels was addressed in the statistical analyses performed on 
SYSTAT Version 5.1. Tukey's HSD comparisons tests is a highly conservative statistical 
analyses that allows pairwise differences that are not obvious between the synthetic diet 
treatments to be addressed. Tukey's HSD comparisons tests measures the pairwise mean 
differences between the replicate cages and also calculates the associated probabilities of 
the closeness of the values. Any associated probability that is less than 0.05 is considered 
significant. Tukey's HSD comparisons tests showed that mice supplemented with 800 
IU/kg vitamin E, Cage D, had similar antibody levels as mice supplemented with 800 
IU/kg vitamin E plus 2 ppm selenium, Cage C. Also, the mice supplemented with 2 ppm 
selenium, Cage B, had similar antibody levels as mice deficient in vitamin E and selenium, 
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Cage A. Cages A and B differed significantly from Cages C and D (Table 3). Thus, there 
were significant differences in the antibody levels between the synthetic diet treatment 
cages that was detectable by utilizing the Tukey's HSD comparisons tests. The elevated 
vitamin E levels supplemented in the synthetic diets appeared to be the dividing factor in 
this study. Therefore, increased dietary vitamin E did have a significant effect on antibody 
level production during the course of Chagas' disease in this study while the elevated 
selenium level did not have a statistically significant effect on the response of the mice. 
The increase in antibody levels should directly reflect an increase in circulating 
peripheral parasites as the amastigote stage of the parasite changes into the infective 
trypomastigote and is released into the blood stream. Each new wave of trypomastigotes 
released after the onset of the initial infection would encounter an already primed immune 
response that would result in a stronger secondary response to the parasite. These results 
are suggestive that increased dietary intake of the antioxidant, vitamin E, can possibly 
enhance the humoral immune response of mice with Chagas' disease. 
Although the humoral immunity plays an important role in the protective response 
to Chagas' disease, cell mediated immunity has also been shown to be crucial (Romach et 
al., 1993; Chandra, 1992; Corwin and Schloss, 1980, Tarleton, 1991). However, the 
effect of vitamin E and selenium supplementation on cell-mediated immunity was not 
addressed in the present study. 
The percent survival of 44.5% for the mice supplemented with 2 ppm selenium 
was close to the percent survival of the mice fed the synthetic diet that was deficient in 
vitamin E and selenium. These percent survival results led to the hypothesis that the level 
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of selenium used in this study was perhaps too low for an enhancement effect to be noted. 
To circumvent the synthetic food effect, a second study using a selenium salt dissolved in 
the drinking water of the mice was undertaken by a separate research group. The highest 
percent survival observed in this study was for mice that received 8 ppm selenium in their 
drinking water. Previous research by Spallholz (1975) had documented hair loss and 
lethargy at elevated selenium levels of 16 ppm, but the only outward clinical symptom that 
was noted in the second study was hyperactivity. It is possible that optimal levels of 
selenium can be determined from the combination of the second study with the present 
thesis study. 
The results from the present study demonstrate that increased dietary vitamin E 
can exert a significant positive impact on the course of experimental Chagas' disease in 
C3HeB/FeJ mice resulting in a depression in parasitemia and an increase in survival. The 
mechanisms responsible for this alteration in the normal course of Chagas' disease after 
infection with a lethal dose of T. cruzi were not addressed in this study. 
The potential impact of the role of antioxidants on overall health and resistance to 
infectious diseases should be investigated further. The increasing numbers of people 
infected with diseases such as drug-resistant tuberculosis and Acquired Immunodeficiency 
Syndrome (AIDS) make the significance of this study more meaningful because of the 
emergence of "new" diseases and the resurgence of diseases once thought to be 
eradicated. Wang et al. (1994) reported that the immune response of female C57BL/6 
mice with AIDS was enhanced by dietary vitamin E supplementation. This study 
measured specific cytokines that are known to be necessary in the response to Human 
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Immunodeficiency Virus (HIV) infection. The authors of that study suggested a 
combination of existing medical therapy with nutritional supplementation may provide a 
more successful treatment approach for HIV-infected individuals (Wang et al., 1994). 
Antibiotics are not as useful as they once were against many microorganisms; therefore, 
the immune enhancing ability of antioxidants, such as vitamin E and selenium, may become 
more important for humans in their war against pathogenic microorganisms. 
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